TABLE 3.
Basic clinical characteristics of KIRP patients in validation cohort.
Characteristic | Levels | Overall |
---|---|---|
n | 30 | |
Pathologic T stage, n (%) | T1 | 21 (70%) |
T2 | 3 (10%) | |
T3 | 3 (10%) | |
T4 | 3 (10%) | |
Pathologic N stage, n (%) | N0 | 18 (60%) |
N1 | 9 (30%) | |
N2 | 3 (10%) | |
Pathologic M stage, n (%) | M0 | 27 (90%) |
M1 | 3 (10%) | |
Pathologic stage, n (%) | Stage I | 18 (60%) |
Stage II | 3 (10%) | |
Stage III | 6 (20%) | |
Stage IV | 3 (10%) | |
Gender, n (%) | Female | 9 (30%) |
Male | 21 (70%) | |
Age, n (%) | <=60 | 15 (50%) |
>60 | 15 (50%) | |
Age, median (IQR) | 62 (55, 70) |